Barclays’s CRH Medical Corporation CRHM Stock Holding History

Barclays’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-258,202	Closed	-$1.02M	–	5202
2021 Q1	$1.02M	Buy	+258,202	New	+$835K	﹤0.01%	2765
2017 Q3	–	Sell	-96,000	Closed	-$547K	–	7148
2017 Q2	$547K	Sell	96,000 -16,000	-14%	-$104K	﹤0.01%	3435
2017 Q1	$918K	Buy	112,000 +41,000	+58%	+$284K	﹤0.01%	2812
2016 Q4	$373K	Buy	+71,000	New	+$360K	﹤0.01%	3649

Barclays's CRHM Position: Q2 2021 in Review

Barclays sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 258,202 shares — an estimated $1.02M sold.

Barclays first reported a position in CRHM in Q4 2016 and held it in 4 quarters. The position peaked at $1.02M in Q1 2021. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.

Barclays reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
Barclays sold 258,202 CRH Medical Corporation shares in Q2 2021, an estimated $1.02M.
Barclays first reported a position in CRH Medical Corporation in Q4 2016 and held it in 4 quarters.
Barclays's CRH Medical Corporation position peaked at $1.02M in Q1 2021.
1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.